X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (414) 414
index medicus (343) 343
female (251) 251
mutation (185) 185
oncology (175) 175
cancer (169) 169
genetic aspects (136) 136
congenital, hereditary, and neonatal diseases and abnormalities (119) 119
male (118) 118
middle aged (118) 118
adult (112) 112
genetic predisposition to disease (111) 111
breast cancer (107) 107
genetics & heredity (106) 106
genetics (87) 87
genes (85) 85
aged (81) 81
research (81) 81
animals (79) 79
breast neoplasms - genetics (76) 76
tumors (75) 75
risk factors (68) 68
ovarian cancer (65) 65
gene mutations (63) 63
germ-line mutation (63) 63
colorectal neoplasms, hereditary nonpolyposis - genetics (62) 62
risk (62) 62
proteins (59) 59
germline mutations (58) 58
breast-cancer (57) 57
colorectal cancer (56) 56
medicine & public health (56) 56
microsatellite instability (56) 56
brca1 (55) 55
analysis (54) 54
health aspects (53) 53
mutations (53) 53
ovarian-cancer (53) 53
brca1 protein - genetics (52) 52
dna repair (52) 52
genetic testing (50) 50
pathology (49) 49
skin and connective tissue diseases (49) 49
deoxyribonucleic acid--dna (48) 48
human genetics (48) 48
immunohistochemistry (47) 47
diagnosis (46) 46
gene (45) 45
neoplastic syndromes, hereditary - genetics (45) 45
biochemistry & molecular biology (44) 44
pedigree (44) 44
nonpolyposis colorectal-cancer (43) 43
review (43) 43
cell biology (41) 41
nutritional and metabolic diseases (41) 41
ovarian neoplasms - genetics (40) 40
phenotype (38) 38
cancer research (37) 37
care and treatment (37) 37
dna mismatch repair (37) 37
gene expression (37) 37
lynch syndrome (37) 37
aged, 80 and over (36) 36
medicine (36) 36
brca2 (35) 35
genes, brca1 (35) 35
carcinoma (34) 34
cell line, tumor (33) 33
dna (33) 33
prognosis (33) 33
research article (33) 33
brca2 protein - genetics (32) 32
dna mutational analysis (32) 32
endocrinology & metabolism (32) 32
mice (32) 32
multidisciplinary sciences (32) 32
biomedicine (31) 31
epidemiology (31) 31
genetic research (31) 31
adolescent (30) 30
breast neoplasms - metabolism (30) 30
dna damage (30) 30
gene expression regulation, neoplastic (30) 30
genetic counseling (30) 30
genomics (30) 30
hereditary breast and ovarian cancer syndrome - genetics (30) 30
patients (30) 30
development and progression (29) 29
expression (29) 29
genes, brca2 (29) 29
hereditary (29) 29
mismatch repair (29) 29
colorectal-cancer (27) 27
genetic screening (27) 27
hereditary breast (27) 27
lynch-syndrome (27) 27
mutl protein homolog 1 (27) 27
neoplasms - genetics (27) 27
abridged index medicus (26) 26
brca1 protein - metabolism (26) 26
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BioMed research international, ISSN 2314-6141, 2015, Volume 2015, pp. 1 - 11
...% of these cases, the genetic abnormality is a germline mutation in genes. Nevertheless, several other suppressor genes and oncogenes have been associated with hereditary ovarian cancers, including the mismatch repair... 
BREAST-CANCER | MEDICINE, RESEARCH & EXPERIMENTAL | LYNCH-SYNDROME | LI-FRAUMENI-SYNDROME | CLEAR-CELL | INCREASED RISK | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MICROSATELLITE INSTABILITY | GERMLINE MUTATIONS | EARLY-ONSET | FALLOPIAN-TUBE | CLINICAL CHARACTERISTICS | Genetic Predisposition to Disease | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - pathology | Humans | Ovarian Neoplasms - pathology | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - metabolism | Li-Fraumeni Syndrome - genetics | Li-Fraumeni Syndrome - pathology | Colorectal Neoplasms, Hereditary Nonpolyposis - therapy | BRCA2 Protein - metabolism | Li-Fraumeni Syndrome - therapy | Li-Fraumeni Syndrome - metabolism | BRCA1 Protein - metabolism | DNA Mismatch Repair | Ovarian Neoplasms - therapy | Female | Ovarian Neoplasms - metabolism | BRCA2 Protein - genetics | Genetic disorders | Oncology, Experimental | Physiological aspects | Genetic aspects | Research | Ovarian cancer | Cancer | Women | Pathogenesis | Decision making | Gynecology | Breast cancer | Gene expression | Obstetrics | Hospitals | Genetic counseling | Surveillance | Medical prognosis | Tumorigenesis | Mutation | Behavior | Tumors | Review
Journal Article
Journal Article
Canadian Medical Association Journal, ISSN 0820-3946, 2019, Volume 191, Issue 32, pp. E886 - E893
Journal Article
Journal Article
Journal Article
Journal Article
Nature (London), ISSN 1476-4687, 2018, Volume 562, Issue 7726, pp. 217 - 222
Journal Article
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 52 - 59
Abstract Drug resistance to conventional anticancer therapies is almost inevitable in patients with advanced ovarian cancer (AOC... 
Hematology, Oncology and Palliative Medicine | RMH prognostic score | Precision medicine | Antiangiogenics | Phase I trials | Poly(ADP-ribose) Polymerase (PARP) inhibitors | Ovarian cancer | TARGETED THERAPY | BEVACIZUMAB | FALLOPIAN-TUBE | BREAST | CHEMOTHERAPY | PIK3CA | ONCOLOGY | PERSPECTIVES | MUTATIONS | RECURRENT EPITHELIAL OVARIAN | PRIMARY PERITONEAL | Neoplasms, Cystic, Mucinous, and Serous - metabolism | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | England | Antineoplastic Agents - therapeutic use | Granulosa Cell Tumor - pathology | Carcinoma, Endometrioid - metabolism | Neoplasms, Cystic, Mucinous, and Serous - genetics | Ovarian Neoplasms - genetics | Neoplasm Metastasis | Genes, BRCA2 | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Granulosa Cell Tumor - drug therapy | Leukocyte Count | Membrane Proteins - metabolism | Ovarian Neoplasms - metabolism | Retrospective Studies | Genes, BRCA1 | CA-125 Antigen - metabolism | Ovarian Neoplasms - drug therapy | Carcinosarcoma - pathology | Severity of Illness Index | Hereditary Breast and Ovarian Cancer Syndrome - genetics | Carcinoma, Endometrioid - genetics | Carcinosarcoma - metabolism | Neoplasms, Cystic, Mucinous, and Serous - pathology | Adenocarcinoma, Clear Cell - metabolism | Granulosa Cell Tumor - genetics | Hemoglobins - metabolism | Survival Rate | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Drug Discovery | Granulosa Cell Tumor - metabolism | Adenocarcinoma, Clear Cell - pathology | Aged | Carcinosarcoma - drug therapy | Carcinosarcoma - genetics | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Clinical Trials, Phase I as Topic | Adenocarcinoma, Clear Cell - drug therapy | Serum Albumin - metabolism | Chemotherapy | Cancer patients | Clinical trials | Hemoglobin | Metastasis | Drug resistance | Sugars | Cancer | Monosaccharides
Journal Article
Familial Cancer, ISSN 1389-9600, 12/2015, Volume 14, Issue 4, pp. 505 - 513
...). We analyze the results of a multicenter study performed in Spanish familial MBC including family history of hereditary breast and ovarian cancer syndrome (HBOCS... 
Human Genetics | Biomedicine | Hereditary breast and ovarian cancer syndrome | Cancer Research | BRCA2 mutations | BRCA1 | Familial male breast cancer | Epidemiology | Biomedicine general | SUSCEPTIBILITY | BREAST/OVARIAN CANCER | IDENTIFICATION | REARRANGEMENTS | GENE | ELECTROPHORESIS | ONCOLOGY | RECURRENT | RECOMMENDATIONS | GENETICS & HEREDITY | GERMLINE MUTATIONS | EARLY-ONSET | Carcinoma, Ductal, Breast - genetics | Breast Neoplasms, Male - genetics | Carcinoma, Lobular - pathology | Carcinoma, Ductal, Breast - epidemiology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma, Lobular - epidemiology | Male | Germ-Line Mutation - genetics | Genetic Testing - methods | Immunoenzyme Techniques | Ovarian Neoplasms - genetics | Young Adult | Carcinoma, Lobular - genetics | BRCA1 Protein - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Carcinoma, Ductal, Breast - pathology | Female | Breast Neoplasms, Male - epidemiology | Genetic Predisposition to Disease | Neoplasm Invasiveness | Syndrome | Ovarian Neoplasms - epidemiology | BRCA1 Protein - genetics | BRCA2 Protein - metabolism | Spain - epidemiology | Aged | Biomarkers, Tumor - genetics | Breast Neoplasms, Male - pathology | Neoplasm Staging | BRCA2 Protein - genetics | Immunohistochemistry | BRCA mutations | Analysis | Oncology, Experimental | Genetic research | Breast cancer | Genetic aspects | Research | Cancer
Journal Article